VIO Imaging for Skin Tissue Assessment (VISTA)

To demonstrate the safety and effectiveness of the VIO device in obtaining in vivo images that show tissue features including epidermis, dermis, collagen, blood vessels, and/or pigment.To demonstrate that the tissue features identified on the images obtained with the VIO device align with the corresponding pathology images procured from the skin biopsy.To evaluate the ability of blinded readers to correctly identify tissue features on images obtained with the VIO device.

Inclusion Criteria:The subject is between 18 and 99 years of age.The subject or Legally Authorized Representative (LAR) is able and willing to provide written informed consent.The subject is planning to undergo a routine skin biopsy.The subject is willing and able to remain still for periods of up to 3 minutes to allow for image capture.The subject or LAR has sufficient mental capacity to understand the informed consent form (ICF) and comply with the protocol requirements.Exclusion Criteria:The subject has a general health condition or systemic disease that in the opinion of the physician, precludes them from trial participation.The subject has a known allergy or increased skin sensitivity to silicone, adhesives, or glycerin.The subject's lesion targeted for biopsy:Is located on the palms of the hands, soles of the feet, fingernails, or toenails.Has dense hair that will not be removed prior to the skin biopsy.Has clinically significant abraded or ulcerated skin with or without discharge.Is associated with a wound or skin condition that in the opinion of the physician precludes them from participationIs located in mucosal tissue (i.e., oral, nasal, etc.).Is on tattooed skin.Is on a skin formation too tortuous for the investigational device to access (e.g., skin tags.)Is located in the periorbital region or directly on the eyelid.-